Skip to main content

Articles

Page 136 of 151

  1. Interleukin-1 receptor antagonist (IL-1Ra) is a natural IL-1 inhibitor possessing anti-inflammatory properties. IL-1Ra is produced as different isoforms, one secreted (sIL-1Ra) and three intracellular (icIL-1R...

    Authors: Gaby Palmer, Pierre-Andre Guerne, Francoise Mezin, Michel Maret, Jerome Guicheux, Mary B Goldring and Cem Gabay
    Citation: Arthritis Research & Therapy 2002 4:226
  2. Proteinase-3 (PR-3) is a neutral serine proteinase present in azurophil granules of human polymorphonuclear leukocytes and serves as the major target antigen of antineutrophil cytoplasmic antibodies with a cyt...

    Authors: Holger Brockmann, Andreas Schwarting, Jörg Kriegsmann, Peter Petrow, Andreas Gaumann, Klaus-Michael Müller, Peter Robert Galle and Werner Mayet
    Citation: Arthritis Research & Therapy 2002 4:220
  3. We are developing retroviral-mediated gene transfer to human fibroblast-like synovial cells (FLS) as one approach to characterizing genetic pathways involved in synoviocyte pathophysiology. Prior work has sugg...

    Authors: Jianmin Yang, Michael S Friedman, Huimin Bian, Leslie J Crofford, Blake Roessler and Kevin T McDonagh
    Citation: Arthritis Research & Therapy 2002 4:215
  4. In chronic inflammatory foci, such as the rheumatoid joint, there is enhanced recruitment of phagocytes from the blood into the tissues. Chemokines are strongly implicated in directing the migration of these c...

    Authors: Angela M Patterson, Caroline Schmutz, Scott Davis, Lucy Gardner, Brian A Ashton and Jim Middleton
    Citation: Arthritis Research & Therapy 2002 4:209
  5. Angiopoietins (Ang) are vascular endothelial cell-specific growth factors that play important roles principally during the later stages of angiogenesis. We have compared the distribution of the receptor tyrosi...

    Authors: Shiva Shahrara, Michael V Volin, Matthew A Connors, G Kenneth Haines and Alisa E Koch
    Citation: Arthritis Research & Therapy 2002 4:201
  6. Although early antibiotic treatment of patients with septic arthritis eradicates bacteria, joint destruction commonly results from the unregulated host inflammatory responses to infection. The spin trap compou...

    Authors: Egidija Sakiniene and L Vincent Collins
    Citation: Arthritis Research & Therapy 2002 4:196
  7. Tissue factor (TF) is a transmembrane glycoprotein and the main triggering element of blood coagulation. TF expression on monocytes and endothelial cells is induced by exposure to endotoxin, tumor necrosis fac...

    Authors: Maria I Bokarewa, James H Morrissey and Andrej Tarkowski
    Citation: Arthritis Research & Therapy 2002 4:190
  8. The aim of this study was to analyze the differential effects of three anti-CD4 monoclonal antibodies (mAbs) (with distinct epitope specifities) in the treatment of rat adjuvant arthritis (AA) and on T-cell fu...

    Authors: Dirk Pohlers, Carsten B Schmidt-Weber, Angels Franch, Jürgen Kuhlmann, Rolf Bräuer, Frank Emmrich and Raimund W Kinne
    Citation: Arthritis Research & Therapy 2002 4:184
  9. A study was done to determine if the differentiation and activation phenotype of T cells in synovial fluid (SF) from patients with juvenile idiopathic arthritis (JIA) is associated with T-cell proliferation in si...

    Authors: Antony PB Black, Hansha Bhayani, Clive AJ Ryder, Janet MM Gardner-Medwin and Taunton R Southwood
    Citation: Arthritis Research & Therapy 2002 4:177
  10. Systemic sclerosis (SSc) is a multisystem connective tissue disease characterised phenotypically by fibrosis and ischaemic atrophy. Its aetiology is most likely multifactorial. A genetic predisposition to the ...

    Authors: Ariane L Herrick and Jane Worthington
    Citation: Arthritis Research & Therapy 2002 4:165
  11. Matrix metalloproteinase (MMP)-1, MMP-8 and MMP-13 are interstitial collagenases that degrade type II collagen in cartilage; this is a committed step in the progression of rheumatoid arthritis and osteoarthrit...

    Authors: Matthew P Vincenti and Constance E Brinckerhoff
    Citation: Arthritis Research & Therapy 2002 4:157
  12. IL-6 is a multifunctional cytokine produced by lymphoid and nonlymphoid cells; it regulates immune responses, acute-phase reactions, and inflammation. IL-6 signaling is mediated exclusively by the common signa...

    Authors: Tetsuji Naka and Tadamitsu Kishimoto
    Citation: Arthritis Research & Therapy 2002 4:154
  13. The use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) to reduce serum cholesterol is well described. However, the recent finding that statins have direct effects on bone was unexpecte...

    Authors: Christopher J Edwards and Tim D Spector
    Citation: Arthritis Research & Therapy 2002 4:151
  14. It is not known to what extent glucocorticoid hormones cause their anti-inflammatory actions and their undesirable side effects by the same or different molecular mechanisms. Glucocorticoids combine with a cyt...

    Authors: Jeremy Saklatvala
    Citation: Arthritis Research & Therapy 2002 4:146
  15. Several agents show an effect on reducing radiographic progression in rheumatoid arthritis. It is tempting to retrospectively compare the effects of these agents on radiographic progression across clinical tri...

    Authors: Désirée van der Heijde
    Citation: Arthritis Research & Therapy 2002 4(Suppl 2):S29

    This article is part of a Supplement: Volume 4 Supplement 2

  16. Since the initial characterization of tumor necrosis factor alpha (TNFα), it has become clear that TNFα has diverse biologic activity. The realization that TNFα plays a role in rheumatoid arthritis (RA) has le...

    Authors: Ravinder N Maini and Marc Feldmann
    Citation: Arthritis Research & Therapy 2002 4(Suppl 2):S22

    This article is part of a Supplement: Volume 4 Supplement 2

  17. With the introduction of new disease-modifying antirheumatic drugs (DMARDs) and other therapeutic agents, the management of rheumatoid arthritis (RA) has shifted toward earlier, more aggressive therapy. The ul...

    Authors: Ferdinand C Breedveld
    Citation: Arthritis Research & Therapy 2002 4(Suppl 2):S16

    This article is part of a Supplement: Volume 4 Supplement 2

  18. Despite the recent introduction of biological response modifiers and potent new small-molecule antirheumatic drugs, the efficacy of methotrexate is nearly unsurpassed in the treatment of inflammatory arthritis...

    Authors: Edwin SL Chan and Bruce N Cronstein
    Citation: Arthritis Research & Therapy 2002 4:266
  19. Regulatory T cells prevent autoimmunity by suppressing the reactivity of potentially aggressive self-reactive T cells. Contact-dependent CD4+ CD25+ 'professional' suppressor cells and other cytokine-producing CD4

    Authors: David A Horwitz, J Dixon Gray and Song Guo Zheng
    Citation: Arthritis Research & Therapy 2002 4:241
  20. Tendon pathology has many manifestations, from spontaneous rupture to chronic tendinitis or tendinosis; the etiology and pathology of each are very different, and poorly understood. Tendon is a comparatively p...

    Authors: Steven A Fenwick, Brian L Hazleman and Graham P Riley
    Citation: Arthritis Research & Therapy 2002 4:252
  21. Authors: AB Blom, PLEM van Lent, TRDJ Radstake, AEM Holthuysen, AW Slöetjes, RL Smeets, P Barrera, LAB Joosten and WB van den Berg
    Citation: Arthritis Research & Therapy 2002 4(Suppl 1):15

    This article is part of a Supplement: Volume 4 Supplement 1

Annual Journal Metrics

  • 2022 Citation Impact
    4.9 - 2-year Impact Factor
    5.7 - 5-year Impact Factor
    1.501 - SNIP (Source Normalized Impact per Paper)
    1.592 - SJR (SCImago Journal Rank)

    2023 Speed
    11 days submission to first editorial decision for all manuscripts (Median)
    111 days submission to accept (Median)

    2023 Usage 
    3,331,819 downloads
    1,885 Altmetric mentions